Click a link below to view the mailing archive as if it had been sent to you.
| 2017-03-31 12:15 | | Could Pfizer Buy Esperion Therapeutics? and more... |
| 2017-03-31 00:15 | | Kickbacks judge to Novartis: Hand over the info on those 79,000 'sham' events and more... |
| 2017-03-30 12:15 | | How Much Pain Will Congress Inflict on These Opioid Drugmakers' Stocks? and more... |
| 2017-03-30 00:15 | | Gilead's Harvoni ads go from before to after with new creative focused on hep C cure and more... |
| 2017-03-29 12:15 | | Can a $37,000 price be right? For Dupixent, analysts (and one payer) say yes and more... |
| 2017-03-29 00:15 | | Roche secures FDA approval for Ocrevus for two types of MS and more... |
| 2017-03-28 12:15 | | Trumpcare’s demise augurs ill for medical device tax repeal and more... |
| 2017-03-28 00:15 | | Pfizer Up on Bristol-Myers Takeover Talk and more... |
| 2017-03-27 12:15 | | Alexion Pharma, Still Recovering From Boardroom Troubles, Appoints New CEO and more... |
| 2017-03-27 00:15 | | 3 Tremendously Promising Diabetes Drugs Potentially on the Way and more... |
| 2017-03-26 12:15 | | A Review Of Concert's Filed PRE 14A: The CTP-656 Saga May Not Be Done Yet and more... |
| 2017-03-26 00:15 | | GOP leaders pull health care bill, with no clear path forward on reform and more... |
| 2017-03-25 12:15 | | Bausch & Lomb Continues to be Key Growth Driver for Valeant and more... |
| 2017-03-24 12:15 | | Drugmaker Lilly to invest $850 mln in U.S. operations in 2017 and more... |
| 2017-03-24 00:15 | | Amgen Identifies Issue with Patient Access to PCSK9 Inhibitor and more... |
| 2017-03-23 12:15 | | Teva Denies Reports About 11% Global Workforce Reduction and more... |
| 2017-03-23 00:15 | | 7 Pharma Plays With Emerging Market Potential and more... |
| 2017-03-22 12:15 | | Novartis’ Heart Drug Fails Late Stage Trials and more... |
| 2017-03-22 00:15 | | Tens of thousands of EpiPens recalled for faulty mechanism and more... |
| 2017-03-21 12:15 | | Pharma's rep with patient groups was on the rise, but not anymore and more... |
| 2017-03-21 00:15 | | Phase 3 win moves Lilly's breast cancer drug closer to market and more... |
| 2017-03-20 12:15 | | Diabetes meds from AZ, J&J and Lilly sharply cut death rates in real-world analysis and more... |
| 2017-03-20 00:15 | | No opioids, please: A growing movement lets patients refuse prescriptions and more... |
| 2017-03-19 12:15 | | Amgen Blew It…For Medicines Co., Esperion Too and more... |
| 2017-03-18 12:15 | | 4 milestones to get your medical device idea from prototype to commercialization: Interview with Eric Stone, CEO of Velano Vascular and more... |
| 2017-03-17 12:15 | | Amgen Drug Prevents Heart Attacks, Not Deaths, Disappointing Experts and more... |
| 2017-03-17 00:15 | | Roche trims workforce in struggling U.S. diabetes market and more... |
| 2017-03-16 12:15 | | Trump budget calls for slashing biomedical and science research funding and more... |
| 2017-03-16 00:15 | | Wyden Introduces Bill to Increase Transparency of PBMs and more... |
| 2017-03-15 12:15 | | FDA OKs Merck’s Keytruda for Hodgkin lymphoma, a first in blood cancer and more... |
| 2017-03-15 00:15 | | Charles River Laboratories International Inc. Agrees to Pay United States $1.8 Million to Settle False Claims Act Allegations and more... |
| 2017-03-14 12:15 | | Valeant: Why Ackman Bailed and more... |
| 2017-03-14 00:15 | | SXSW panel: IBM, Johnson & Johnson CEOs say tech, medicine collaboration offers huge upside and more... |
| 2017-03-13 12:15 | | Biopharma execs give Scott Gottlieb’s nomination for FDA commish (almost) a standing O in Endpoints poll and more... |
| 2017-03-12 12:15 | | How Will the American Health Care Act Change Health Care? and more... |
| 2017-03-11 12:15 | | Payor Re-Evaluation On Exondys Positive For Sarepta and more... |
| 2017-03-11 00:15 | | The new CEOs in biopharma are joining the big players at the billion-dollar chip table and more... |
| 2017-03-10 12:15 | | Novo Nordisk in Talks to Buy Global Blood Therapeutics and more... |
| 2017-03-09 12:15 | | Merck KGaA in talks to sell its biosimilars R&D ops as shakeout looms and more... |
| 2017-03-09 00:15 | | Pfizer wins TRO against ex-marketing manager accused of stealing launch plans and more... |
| 2017-03-08 12:15 | | Do big R&D budgets justify US premium drug prices? No way, analysts scoff and more... |
| 2017-03-08 00:15 | | Drug price moves in ACA repeal? Nope. But a Trump tweet says a 'new system' is coming |
| 2017-03-07 12:15 | | Merck, Pfizer line up a big FDA decision on a blockbuster hopeful, staring down some major league competition and more... |
| 2017-03-07 00:15 | | How the world’s richest doctor gave away millions — then steered the cash back to his company and more... |
| 2017-03-06 12:15 | | Eight senators pile on to Marathon's Emflaza—and its $89,000 pricing blunder and more... |
| 2017-03-06 00:15 | | India wants to sell low-cost drugs in Trump’s America, but quality questions persist and more... |
| 2017-03-05 00:15 | | Celgene, BMS, Novartis expected to top 2022 orphan drug market worth $209B: report and more... |
| 2017-03-04 00:15 | | Amgen: Clinical Trials Set Stage for Further Upside and more... |
| 2017-03-03 12:15 | | Investors pile pressure on GSK over new chief’s pay deal and more... |
| 2017-03-03 00:15 | | 4 Reasons Johnson & Johnson Surged 8% in February and more... |
| 2017-03-02 12:15 | | Twenty More States Accuse Mylan, Teva and Others of Price Collusion and more... |
| 2017-03-02 00:15 | | Big Pharma Pushes Back on Drug-Price Complaints and more... |
| 2017-03-01 12:15 | | Novo rejigs U.S. team as passed-over CEO candidate heads for the door and more... |
| 2017-03-01 00:15 | | Trump attacks “slow and burdensome” drug approval process in another blast crisping the FDA and more... |
